96 related articles for article (PubMed ID: 27686852)
1. Clinical Course of Two Children with Unstable Hemoglobins: The Effect of Hydroxyurea Therapy.
Loovers HM; Tamminga N; Mulder AB; Tamminga RY
Hemoglobin; 2016 Sep; 40(5):341-344. PubMed ID: 27686852
[TBL] [Abstract][Full Text] [Related]
2. The pharmacological manipulation of fetal haemoglobin: trials using hydroxyurea and recombinant human erythropoietin.
el-Hazmi MA; al-Momen A; Warsy AS; Kandaswamy S; Huraib S; Harakati M; al-Mohareb F
Acta Haematol; 1995; 93(2-4):57-61. PubMed ID: 7543719
[TBL] [Abstract][Full Text] [Related]
3. Early detection of response to hydroxyurea therapy in patients with sickle cell anemia.
Ballas SK; McCarthy WF; Guo N; Brugnara C; Kling G; Bauserman RL; Waclawiw MA
Hemoglobin; 2010; 34(5):424-9. PubMed ID: 20854115
[TBL] [Abstract][Full Text] [Related]
4. Clinical and hematological response to hydroxyurea in a patient with Hb Lepore/beta-thalassemia.
Rigano P; Manfré L; La Galla R; Renda D; Renda MC; Calabrese A; Calzolari R; Maggio A
Hemoglobin; 1997 May; 21(3):219-26. PubMed ID: 9140718
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyurea and sodium phenylbutyrate therapy in thalassemia intermedia.
Hoppe C; Vichinsky E; Lewis B; Foote D; Styles L
Am J Hematol; 1999 Dec; 62(4):221-7. PubMed ID: 10589077
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).
Sumoza A; de Bisotti R; Sumoza D; Fairbanks V
Am J Hematol; 2002 Nov; 71(3):161-5. PubMed ID: 12410569
[TBL] [Abstract][Full Text] [Related]
7. Long-term hydroxyurea therapy in beta-thalassaemia patients.
de Paula EV; Lima CS; Arruda VR; Alberto FL; Saad ST; Costa FF
Eur J Haematol; 2003 Mar; 70(3):151-5. PubMed ID: 12605659
[TBL] [Abstract][Full Text] [Related]
8. HbSD-Punjab: clinical and hematological profile of a rare hemoglobinopathy.
Oberoi S; Das R; Trehan A; Ahluwalia J; Bansal D; Malhotra P; Marwaha RK
J Pediatr Hematol Oncol; 2014 Apr; 36(3):e140-4. PubMed ID: 24276032
[TBL] [Abstract][Full Text] [Related]
9. Response to hydroxycarbamide in pediatric β-thalassemia intermedia: 8 years' follow-up in Egypt.
El-Beshlawy A; El-Ghamrawy M; EL-Ela MA; Said F; Adolf S; Abdel-Razek AR; Magdy RI; Abdel-Salam A
Ann Hematol; 2014 Dec; 93(12):2045-50. PubMed ID: 25062719
[TBL] [Abstract][Full Text] [Related]
10. Fetal hemoglobin response to hydroxyurea in Yemeni sickle cell disease patients.
Al-Nood HA; Al-Khawlani MM; Al-Akwa A
Hemoglobin; 2011; 35(1):13-21. PubMed ID: 21250877
[TBL] [Abstract][Full Text] [Related]
11. Thrombosis Tendency After Splenectomy in a Danish Family With Hemoglobin Volga, and a Literature Review.
Breinholt JK; Glenthøj A; Bor MV
Hemoglobin; 2024 Mar; 48(2):79-86. PubMed ID: 38565203
[TBL] [Abstract][Full Text] [Related]
12. Cellular effects of hydroxyurea in Hb SC disease.
Steinberg MH; Nagel RL; Brugnara C
Br J Haematol; 1997 Sep; 98(4):838-44. PubMed ID: 9326175
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary hypertension in a case of Hb-Mainz hemolytic anemia.
Lode HN; Krings G; Schulze-Neick I; Dähmlow S; Schroeder U; Bonnet R; DaPalma J; Luck W; Strauss G; Berger F; Gaedicke G
J Pediatr Hematol Oncol; 2007 Mar; 29(3):173-7. PubMed ID: 17356397
[TBL] [Abstract][Full Text] [Related]
14. The first Chinese with Hb Chile leading to chronic anemia and methemoglobinemia: a case report.
Gong Y; Zheng Q; Long S; Chen H; Liu W; Li C
BMC Pediatr; 2023 Dec; 23(1):639. PubMed ID: 38110882
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyurea-induced oxidative damage of normal and sickle cell hemoglobins in vitro: amelioration by radical scavengers.
Iyamu EW; Fasold H; Roa D; del Pilar Aguinaga M; Asakura T; Turner EA
J Clin Lab Anal; 2001; 15(1):1-7. PubMed ID: 11170226
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyurea in the treatment of major beta-thalassemia and importance of genetic screening.
Alebouyeh M; Moussavi F; Haddad-Deylami H; Vossough P
Ann Hematol; 2004 Jul; 83(7):430-3. PubMed ID: 14722738
[TBL] [Abstract][Full Text] [Related]
17. Severe hemolytic anemia associated with Hb Volga [beta27(B9)Ala-->Asp]: GCC-->GAC at codon 27 in a Turkish family.
Sözen M; Karaaslan C; Oner R; Gümrük F; Ozdemir MA; Altay C; Gürgey A; Oner C
Am J Hematol; 2004 Aug; 76(4):378-82. PubMed ID: 15282673
[TBL] [Abstract][Full Text] [Related]
18. Hb Koln [β98(FG5) [GTG → ATG, Val → Met]: the first report from India.
Warang P; Nair S; Nadkarni A; Kedar P; Bhave A; Ghosh K; Colah R
Hematology; 2014 Jun; 19(4):199-201. PubMed ID: 24074398
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyurea-induced hematological response in transfusion-independent beta-thalassemia intermedia: case series and review of literature.
Ehsani MA; Hedayati-Asl AA; Bagheri A; Zeinali S; Rashidi A
Pediatr Hematol Oncol; 2009 Nov; 26(8):560-5. PubMed ID: 19954365
[TBL] [Abstract][Full Text] [Related]
20. Low fixed-dose hydroxyurea in severely affected Indian children with sickle cell disease.
Jain DL; Sarathi V; Desai S; Bhatnagar M; Lodha A
Hemoglobin; 2012; 36(4):323-32. PubMed ID: 22734586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
